← Leaderboards
Colin S. Duckett
Clinical Sciences
$6,553,216
Attributed
$6,553,216
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$6,553,216 · 4
By mechanism
UC7$3,873,596 · 2
R01$2,679,620 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisProteinsBinding ProteinsSignal Transduction PathwayPropertySignal TransductionMalignant NeoplasmsXenograft ProcedureLeadBasePhysiologicalBinding (Molecular Function)Cell LineSignal PathwayLaboratoriesApoptoticPathway InteractionsTumorCancer TherapyLymphomaNeoplastic CellTransforming Growth FactorsDesignCells
Grant awards (21)
Core 3: Biocontainment Research Support Services Core$957,509
UC7 · FY2024 · AI · contact PI
Core 1: Facility Management, Maintenance and Operations Core$953,343
UC7 · FY2024 · AI · contact PI
Core 3: Biocontainment Research Support Services Core$1,029,538
UC7 · FY2023 · AI · contact PI
Core 1: Facility Management, Maintenance and Operations Core$933,206
UC7 · FY2023 · AI · contact PI
Signal Transduction Pathways in CD30-positive Lymphomas$300,886
R01 · FY2014 · CA · contact PI
Signal Transduction Pathways in CD30-positive Lymphomas$291,581
R01 · FY2013 · CA · contact PI
Signal Transduction Pathways in CD30-positive Lymphomas$310,192
R01 · FY2012 · CA · contact PI
Signal Transduction Pathways in CD30-positive Lymphomas$309,234
R01 · FY2011 · CA · contact PI
Signal Transduction Pathways in CD30-positive Lymphomas$137,479
R01 · FY2010 · CA · contact PI
Control of Apoptosis and Signaling by XIAP$247,556
R01 · FY2009 · GM · contact PI
Control of Apoptosis and Signaling by XIAP$67,594
R01 · FY2009 · GM · contact PI
Control of Apoptosis and Signaling by XIAP$247,950
R01 · FY2008 · GM · contact PI
Control of Apoptosis and Signaling by XIAP$248,334
R01 · FY2007 · GM · contact PI
Control of Apoptosis and Signaling by XIAP$256,134
R01 · FY2006 · GM · contact PI
Control of Apoptosis and Signaling by XIAP$262,680
R01 · FY2005 · GM
Induction of Apoptosis in Lymphoma Cells by Activation o$0
Z01 · FY2002 · SC
Characterization of the Inhibitor of Apoptosis (IAP) Gen$0
Z01 · FY2002 · SC
Inhibitor of Apoptosis (IAP) Gene Family$0
Z01 · FY2001 · SC
Apoptosis in Lymphoma Cells by Activation of CD30$0
Z01 · FY2001 · SC
Characterization of Apoptosis Gene Family Inhibitor$0
Z01 · FY2000 · SC
Induction of Apoptosis in Lymphoma Cells by Activation of CD30$0
Z01 · FY2000 · SC